Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Curna

2008 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of drugs. The company engages in developing, manufacturing and marketing of drugs and therapies for commercializing a distinct single-stranded noncoding RNA-based strategy for upregulating gene expression. It primarily manufactures drugs for the treatment of cancer, heart disease, metabolic disorders and genetic anomalies.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 555 Heritage Drive Alexandria Innovation Center
  • Suite 110
  • Jupiter, FL 33458
  • United States

Curna Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Curna‘s full profile, request access.

Request full access to PitchBook

Curna Executive Team (2)

Name Title Board
Seat
Contact
Info
Joseph Collard Co-Founder & Chief Executive Officer
Claes Wahlestedt Ph.D Co-Founder